摘要
Objective To explore the feasibility of sirolimus as an alternative graft versus host disease (GVHD)prophylaxis in patients with kidney injury after allogeneic hematopoietic stem cell transplantation (allo-HSCT).Methods Medical records of 11 patients in Peking University People’s Hospital from 1 August 2008 to 31October 2022,who received sirolimus instead of cyclosporine to prevent GVHD.
作者
孙葳
SUN Wei(Peking Univ People's Hosp,Peking Univ Hematol Instit,Natl Clin Res Center,Hematol Dis,Beijing Key Lab,Hematopoiet Stem Cell Transplant,Beijing 100044)